ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease
- PMID: 9659257
- PMCID: PMC500636
- DOI: 10.1136/jcp.51.3.183
ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease
Abstract
Plasma homocysteine is emerging as an important risk factor for cardiovascular disease. Measurement in clinical laboratories is feasible by several techniques, including HPLC. Of particular importance is the potential for treatment by dietary modification and vitamin supplements, particularly folic acid. The outcome of vitamin intervention on cardiovascular events is awaited with interest. If the role of homocysteine is confirmed then it may rival cholesterol in importance as a cardiovascular risk factor.
Comment in
-
Homocysteine and cardiovascular disease.J Clin Pathol. 1998 Oct;51(10):713. doi: 10.1136/jcp.51.10.713. J Clin Pathol. 1998. PMID: 10023330 Free PMC article. No abstract available.
Similar articles
-
Homocysteine: a new risk factor for atherosclerosis.Am Fam Physician. 1997 Oct 15;56(6):1607-12, 1615-6. Am Fam Physician. 1997. PMID: 9351429 Review.
-
Assessment of homocysteine as a cardiovascular risk factor in clinical practice.Ann Clin Biochem. 2001 Nov;38(Pt 6):624-32. doi: 10.1258/0004563011901046. Ann Clin Biochem. 2001. PMID: 11732645 Review.
-
Testing for hyperhomocysteinemia in subjects with a history of thromboembolic events using HPLC technique.Methods Mol Biol. 2013;992:383-6. doi: 10.1007/978-1-62703-339-8_31. Methods Mol Biol. 2013. PMID: 23546731
-
Folic acid and Vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women.Int J Vitam Nutr Res. 1998;68(2):98-103. Int J Vitam Nutr Res. 1998. PMID: 9565824
-
[Recommended dietary allowance of folic acid is insufficient for optimal homocysteine levels].Ned Tijdschr Geneeskd. 1998 Apr 4;142(14):782-6. Ned Tijdschr Geneeskd. 1998. PMID: 9646611 Clinical Trial. Dutch.
Cited by
-
Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.J Clin Psychiatry. 2012 Jun;73(6):843-8. doi: 10.4088/JCP.11m07139. Epub 2012 May 15. J Clin Psychiatry. 2012. PMID: 22687580 Free PMC article. Clinical Trial.
-
A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP.Cancer Prev Res (Phila). 2015 Sep;8(9):864-72. doi: 10.1158/1940-6207.CAPR-15-0029. Epub 2015 Jun 30. Cancer Prev Res (Phila). 2015. PMID: 26130251 Free PMC article. Clinical Trial.
-
Hyperhomocysteinemia: An emerging risk factor for cardiovascular disease.Indian J Clin Biochem. 2003 Jan;18(1):8-14. doi: 10.1007/BF02867659. Indian J Clin Biochem. 2003. PMID: 23105365 Free PMC article.
-
Homocysteine and cardiovascular disease.J Clin Pathol. 1998 Oct;51(10):713. doi: 10.1136/jcp.51.10.713. J Clin Pathol. 1998. PMID: 10023330 Free PMC article. No abstract available.
-
The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients.Int Urol Nephrol. 2010 Mar;42(1):211-8. doi: 10.1007/s11255-009-9625-y. Epub 2009 Aug 4. Int Urol Nephrol. 2010. PMID: 19653113
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources